Show source-provided references
2. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism
10.1210/jc.2005-1457 ↗4. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: Systematic review and meta-analysis
10.1016/j.fertnstert.2016.07.1121 ↗5. Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age
10.1210/jc.2011-2935 ↗6. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis
10.1093/humupd/dmu012 ↗8. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome
10.5539/gjhs.v7n2p101 ↗9. Evaluation of para- and perirenal fat thickness and its association with metabolic disorders in polycystic ovary syndrome
10.4158/EP14435.OR ↗10. Overweight and obese anovulatory patients with polycystic ovaries: Parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet
10.1093/humrep/deg367 ↗11. Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline
10.1210/jc.2013-2350 ↗12. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod., 19, 41–47.
10.1093/humrep/deh098 ↗13. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome
10.1210/jc.2005-2430 ↗14. Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E.M., Shawki, H.E.D., and Amer, S. (2021). The role of Chronic Inflammation in Polycystic Ovarian Syndrome—A Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 22.
10.3390/ijms22052734 ↗15. Krentowska, A., and Kowalska, I. (2021, May 31). Metabolic Syndrome and Its Components in Different Phenotypes of Polycystic Ovary Syndrome, Available online: https://pubmed.ncbi.nlm.nih.gov/33988288/.
10.1002/dmrr.3464 ↗22. Carter, J.E.L., and Honeyman Heath, B. (1990). Somatotyping: Development and Applications, Cambridge University Press.
24. Medición de la Grasa Corporal Mediante Impedancia Bioeléctrica, Pliegues Cutáneos y Ecuaciones a Partir De Medidas Antropométricas
25. Geronikolou, S.A., Bacopoulou, F., and Cokkinos, D. (2017). Bioimpedance measurements in adolescents with polycystic ovary syndrome: A pilot study. Advances in Experimental Medicine and Biology, Springer LLC.
10.1007/978-3-319-57379-3_26 ↗26. Marroquín Rodríguez, A.L., Cervante, T.J.M., Morales Cortés, L., and Garza Villarreal, E.A. (2012). Somatotipo de la Mujer con Síndrome de Ovario Poliquístico. Somatotype of Women with Polycystic Ovary Syndrome, FML.
27. Presence of polycystic ovary syndrome is associated with longer anogenital distance in adult Mediterranean women
10.1093/humrep/dex274 ↗29. Association of ethnicity, Fitzpatrick skin type, and hirsutism: A retrospective cross-sectional study of women with polycystic ovarian syndrome
10.1016/j.ijwd.2017.01.006 ↗30. The polycystic ovary syndrome: A position statement from the European Society of Endocrinology
10.1530/EJE-14-0253 ↗31. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
10.1007/BF00280883 ↗33. Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome
10.4103/jhrs.JHRS_2_19 ↗34. Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women
10.1186/s13048-016-0260-9 ↗35. The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome
10.1186/s13048-015-0197-4 ↗36. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome
10.1093/humrep/16.6.1255 ↗37. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome
10.1093/humrep/deu096 ↗38. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome
40. Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: The cardiovascular health study
10.1210/jc.2010-0926 ↗41. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and pcos society disease state clinical review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-Part 2. Endocrine Practice
45. Clinical Review 116: Bone mineral density, androgens, and the polycystic ovary: The complex and controversial issue of androgenic influence in female bone
10.1210/jcem.85.10.6902 ↗46. Chen, J.F., Lin, P.W., Tsai, Y.R., Yang, Y.C., and Kang, H.Y. (2019). Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy, NLM. Available online: https://pubmed.ncbi.nlm.nih.gov/31731497/.
10.3390/cells8111318 ↗50. Insulin resistance in polycystic ovary syndrome: A systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies
10.1093/humrep/dew243 ↗55. Negative association between trunk fat, insulin resistance and skeleton in obese women
10.4239/wjd.v4.i2.31 ↗56. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus
10.1172/JCI111938 ↗57. Lean muscle mass in classic or ovulatory PCOS: Association with central obesity and insulin resistance
10.1055/s-0032-1309006 ↗59. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: A monet study
10.1038/oby.2008.23 ↗60. Polycystic ovary syndrome is a risk factor for type 2 diabetes: Results from a long-term prospective study
10.2337/db11-1360 ↗61. The environment and disease: Association or causation?